These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15961791)

  • 1. A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration.
    Ishihara M; Kujiraoka T; Iwasaki T; Nagano M; Takano M; Ishii J; Tsuji M; Ide H; Miller IP; Miller NE; Hattori H
    J Lipid Res; 2005 Sep; 46(9):2015-22. PubMed ID: 15961791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
    Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
    Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The abnormal changes of apolipoprotein(s) in patients with type 2 diabetes mellitus].
    Ren Y; Tian H; Liu B; Liang J; Zhang X; Yao J; Xu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):48-51, 69. PubMed ID: 12733353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
    Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
    Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assay.
    Koren E; Puchois P; McConathy WJ; Fesmire JD; Alaupovic P
    Clin Chim Acta; 1985 Apr; 147(2):85-95. PubMed ID: 3921293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia.
    Schaap FG; Nierman MC; Berbée JF; Hattori H; Talmud PJ; Vaessen SF; Rensen PC; Chamuleau RA; Kuivenhoven JA; Groen AK
    J Lipid Res; 2006 Oct; 47(10):2333-9. PubMed ID: 16861622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-V is a potent modulator of HDL and VLDL components in preadolescent children.
    Abe Y; Okada T; Kuromori Y; Hara M; Saito E; Iwata F; Harada K; Mugishima H
    J Atheroscler Thromb; 2009 Apr; 16(2):121-6. PubMed ID: 19403991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.
    Nelbach L; Shu X; Konrad RJ; Ryan RO; Forte TM
    J Lipid Res; 2008 Mar; 49(3):572-80. PubMed ID: 18056685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.
    Vaessen SF; Schaap FG; Kuivenhoven JA; Groen AK; Hutten BA; Boekholdt SM; Hattori H; Sandhu MS; Bingham SA; Luben R; Palmen JA; Wareham NJ; Humphries SE; Kastelein JJ; Talmud PJ; Khaw KT
    J Lipid Res; 2006 Sep; 47(9):2064-70. PubMed ID: 16769999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
    Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P
    Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum apolipoprotein A-V in patients with coronary artery disease and its association with triglyceride.
    Yang Y; Walijee SM; Jin J; Zhao SP; Peng DQ
    J Clin Lipidol; 2012; 6(5):462-8. PubMed ID: 23009782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics.
    Wung SF; Aouizerat BE
    Res Theory Nurs Pract; 2003; 17(4):281-99; discussion 335-8. PubMed ID: 14959997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender.
    Olano-Martin E; Abraham EC; Gill-Garrison R; Valdes AM; Grimaldi K; Tang F; Jackson KG; Williams CM; Minihane AM
    J Lipid Res; 2008 May; 49(5):945-53. PubMed ID: 18263854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
    Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
    Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A-V level may contribute to the development of obesity-associated dyslipidemia.
    Yoshino Y; Okada T; Abe Y; Odaka M; Kuromori Y; Yonezawa R; Iwata F; Mugishima H
    Obes Res Clin Pract; 2013; 7(5):e415-9. PubMed ID: 24304484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation of plasma glucose levels to serum lipids and apolipoproteins levels in middle and old age males].
    Duan Y; Wu Z; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):382-4. PubMed ID: 12536570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes.
    Kang R; Kim M; Chae JS; Lee SH; Lee JH
    Trials; 2014 Apr; 15():100. PubMed ID: 24690159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans.
    Becker S; Schomburg L; Renko K; Tölle M; van der Giet M; Tietge UJ
    Biochem Biophys Res Commun; 2006 Jan; 339(3):833-9. PubMed ID: 16325772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities.
    Mero N; Van Tol A; Scheek LM; Van Gent T; Labeur C; Rosseneu M; Taskinen MR
    J Lipid Res; 1998 Jul; 39(7):1493-502. PubMed ID: 9684753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.